Loading clinical trials...

Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis | Clinical Trials | Clareo Health

COMPLETEDPhase 3NCT00450086

Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis

The purpose of this study is to determine whether budesonide or mesalazine is more active in the treatment of collagenous colitis.

Lead sponsor: Dr. Falk Pharma GmbH•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

UNKNOWNPhase 3

Rifaximin-treatment of Collagenous Colitis

NCT03658993 · Collagenous Colitis

UNKNOWNNA

Usefulness of Chromoendoscopy in Diagnosing Microscopic Colitis

NCT01504048 · Chronic Diarrhoea, Lymphocytic Colitis, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 19, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment92

Start dateMar 2007

Last updatedMay 19, 2014

Condition

Collagenous Colitis

Locations shown

Center of digestive diseases

Hamburg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 19, 2014Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions